| 1 | [SID11112246] | Active | Potency | 6.3096 | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19 [AID899, Type: confirmatory] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 11112246 | | CID | 7184 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19 | | AID | 899 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 2 | [SID11112246] | Active | Potency | 6.3096 | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19 [AID899, Type: confirmatory] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 11112246 | | CID | 7184 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19 | | AID | 899 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 3 | [SID144203944] | Active | Potency | 30.6379 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 144203944 | | CID | 7184 | | Outcome | Active | | Potency | 30.6379 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 4 | [SID144203944] | Active | Potency | 30.6379 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 144203944 | | CID | 7184 | | Outcome | Active | | Potency | 30.6379 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 5 | [SID144203944] | Active | Potency | 30.6379 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 144203944 | | CID | 7184 | | Outcome | Active | | Potency | 30.6379 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 6 | [SID144203944] | Active | Potency | 30.6379 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 144203944 | | CID | 7184 | | Outcome | Active | | Potency | 30.6379 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 7 | [SID17390002] | Active | Potency | 37.578 | qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay [AID651755, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17390002 | | CID | 7184 | | Outcome | Active | | Potency | 37.578 [uM] | | BioAssay | qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay | | AID | 651755 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID11112246] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 11112246 | | CID | 7184 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 9 | [SID11112246] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 11112246 | | CID | 7184 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 10 | [SID11112246] | Active | | | p450-cyp1a2 [AID410, Type: confirmatory] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 11112246 | | CID | 7184 | | Outcome | Active | | BioAssay | p450-cyp1a2 | | AID | 410 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 11 | [SID11112246] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_4, Type: other] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 11112246 | | CID | 7184 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 12 | [SID11112246] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_4, Type: other] | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 11112246 | | CID | 7184 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 1, subfamily A, polypeptide 2 [Homo sapiens] [gi:73915100] | | PubMed | | | Data Table |  |
|
| 13 | [SID48422015] | Active | | | DSSTox (NCTRER) National Center for Toxicological Research Estrogen Receptor Binding Database [AID1204, Type: screening] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 48422015 | | CID | 7184 | | Outcome | Active | | BioAssay | DSSTox (NCTRER) National Center for Toxicological Research Estrogen Receptor Binding Database | | AID | 1204 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID11112246] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_1, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 11112246 | | CID | 7184 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 15 | [SID11112246] | Active | | | Cytochrome panel assay with activity outcomes [AID1851_1, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 11112246 | | CID | 7184 | | Outcome | Active | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 16 | [SID103647512] | Unspecified | | | Binding affinity to beta cyclodextrin [AID346025, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103647512 | | CID | 7184 | | Outcome | Unspecified | | BioAssay | Binding affinity to beta cyclodextrin | | AID | 346025 | | BioAssay type | Literature | | Target | | | PubMed | 19056282 | | Data Table |  |
|
| 17 | [SID26752916] | Unspecified | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26752916 | | CID | 7184 | | Outcome | Unspecified | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 18 | [SID104171292] | Unspecified | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature] | |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 104171292 | | CID | 7184 | | Outcome | Unspecified | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 19 | [SID11112246] | Unspecified | | | Cytochrome panel assay with activity outcomes [AID1851, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 11112246 | | CID | 7184 | | Outcome | Unspecified | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 20 | [SID11112246] | Unspecified | | | Cytochrome panel assay with activity outcomes [AID1851, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 11112246 | | CID | 7184 | | Outcome | Unspecified | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 21 | [SID26752916] | Unspecified | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26752916 | | CID | 7184 | | Outcome | Unspecified | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID17390002] | Unspecified | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17390002 | | CID | 7184 | | Outcome | Unspecified | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID22405509] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 24 | [SID22405509] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 25 | [SID17390002] | Inactive | Potency | 0.1259 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17390002 | | CID | 7184 | | Outcome | Inactive | | Potency | 0.1259 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 26 | [SID17390002] | Inactive | Potency | 0.1259 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17390002 | | CID | 7184 | | Outcome | Inactive | | Potency | 0.1259 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 27 | [SID17390002] | Inactive | Potency | 0.1259 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17390002 | | CID | 7184 | | Outcome | Inactive | | Potency | 0.1259 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 28 | [SID11112246] | Inactive | Potency | 10 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 11112246 | | CID | 7184 | | Outcome | Inactive | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 29 | [SID17390002] | Inactive | Potency | 10.5909 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17390002 | | CID | 7184 | | Outcome | Inactive | | Potency | 10.5909 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 30 | [SID17390002] | Inactive | Potency | 10.5909 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17390002 | | CID | 7184 | | Outcome | Inactive | | Potency | 10.5909 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 31 | [SID17390002] | Inactive | Potency | 10.5909 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17390002 | | CID | 7184 | | Outcome | Inactive | | Potency | 10.5909 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 32 | [SID17390002] | Inactive | Potency | 10.5909 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17390002 | | CID | 7184 | | Outcome | Inactive | | Potency | 10.5909 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 33 | [SID17390002] | Inactive | Potency | 10.5909 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17390002 | | CID | 7184 | | Outcome | Inactive | | Potency | 10.5909 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 34 | [SID26752916] | Inactive | Potency | 13.3359 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26752916 | | CID | 7184 | | Outcome | Inactive | | Potency | 13.3359 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 35 | [SID22405509] | Inactive | Potency | 14.6892 | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 [AID2288, Type: confirmatory] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Inactive | | Potency | 14.6892 [uM] | | BioAssay | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 | | AID | 2288 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID22405509] | Inactive | Potency | 18.526 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Inactive | | Potency | 18.526 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID104171292] | Inactive | Potency | 32.1968 | S16 Schwann cell PMP22 intronic element firefly luciferase assay [AID624032, Type: confirmatory] | Pmp22 gene product [Rattus norvegicus] [gi:8393992] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 104171292 | | CID | 7184 | | Outcome | Inactive | | Potency | 32.1968 [uM] | | BioAssay | S16 Schwann cell PMP22 intronic element firefly luciferase assay | | AID | 624032 | | BioAssay type | confirmatory | | Target | Pmp22 gene product [Rattus norvegicus] [gi:8393992] | | PubMed | | | Data Table |  |
|
| 38 | [SID22405509] | Inactive | Potency | 89.1251 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 39 | [SID22405509] | Inactive | EC50 | 300 | Luminescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of ADP-glo Reagents [AID434947, Type: confirmatory] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Inactive | | EC50 | 300 [uM] | | BioAssay | Luminescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of ADP-glo Reagents | | AID | 434947 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID22405509] | Inactive | EC50 | 300 | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Inactive | | EC50 | 300 [uM] | | BioAssay | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity | | AID | 434954 | | BioAssay type | confirmatory | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 41 | [SID22405509] | Inactive | EC50 | 300 | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Inactive | | EC50 | 300 [uM] | | BioAssay | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity | | AID | 434954 | | BioAssay type | confirmatory | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 42 | [SID22405509] | Inactive | EC50 | 300 | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Inactive | | EC50 | 300 [uM] | | BioAssay | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity | | AID | 434954 | | BioAssay type | confirmatory | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 43 | [SID22405509] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 44 | [SID22405509] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 45 | [SID22405509] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 46 | [SID11112246] | Inactive | Potency | | qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing [AID925, Type: confirmatory] | hemoglobin subunit beta [Homo sapiens] [gi:4504349] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 11112246 | | CID | 7184 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing | | AID | 925 | | BioAssay type | confirmatory | | Target | hemoglobin subunit beta [Homo sapiens] [gi:4504349] | | PubMed | | | Data Table |  |
|
| 47 | [SID17390002] | Inactive | Potency | | qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing [AID925, Type: confirmatory] | hemoglobin subunit beta [Homo sapiens] [gi:4504349] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17390002 | | CID | 7184 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing | | AID | 925 | | BioAssay type | confirmatory | | Target | hemoglobin subunit beta [Homo sapiens] [gi:4504349] | | PubMed | | | Data Table |  |
|
| 48 | [SID22405509] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 49 | [SID22405509] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 50 | [SID22405509] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 22405509 | | CID | 7184 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|